343 related articles for article (PubMed ID: 22618269)
1. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
[TBL] [Abstract][Full Text] [Related]
2. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
[TBL] [Abstract][Full Text] [Related]
3. Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
Hoff M; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Skovlund E; Abrahamsen B; Forsmo S; Schei B
Osteoporos Int; 2018 Aug; 29(8):1875-1885. PubMed ID: 29774403
[TBL] [Abstract][Full Text] [Related]
4. Comment on Sanfélix-Genovés et al.: Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Pedrera-Zamorano JD; Lavado-Garcia JM; Moran JM
Osteoporos Int; 2013 Jun; 24(6):1923-4. PubMed ID: 23052931
[No Abstract] [Full Text] [Related]
5. The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
Su Y; Leung J; Kwok T
Osteoporos Int; 2018 Feb; 29(2):355-363. PubMed ID: 29067485
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study.
Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G
J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study.
Bhattoa HP; Nagy E; More C; Kappelmayer J; Balogh A; Kalina E; Antal-Szalmas P
Osteoporos Int; 2013 Jan; 24(1):179-86. PubMed ID: 22422303
[TBL] [Abstract][Full Text] [Related]
8. Magnitude of fragility fracture risk in the very old--are we meeting their needs? The Newcastle 85+ Study.
Duncan R; Francis RM; Jagger C; Kingston A; McCloskey E; Collerton J; Robinson L; Kirkwood TB; Birrell F
Osteoporos Int; 2015 Jan; 26(1):123-30. PubMed ID: 25224291
[TBL] [Abstract][Full Text] [Related]
9. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
[TBL] [Abstract][Full Text] [Related]
10. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
[TBL] [Abstract][Full Text] [Related]
11. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study.
Cipriani C; Pepe J; Bertoldo F; Bianchi G; Cantatore FP; Corrado A; Di Stefano M; Frediani B; Gatti D; Giustina A; Porcelli T; Isaia G; Rossini M; Nieddu L; Minisola S; Girasole G; Pedrazzoni M
J Endocrinol Invest; 2018 Apr; 41(4):431-438. PubMed ID: 28956296
[TBL] [Abstract][Full Text] [Related]
13. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
[TBL] [Abstract][Full Text] [Related]
14. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
[TBL] [Abstract][Full Text] [Related]
15. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
Wilk A; Sajjan S; Modi A; Fan CP; Mavros P
Osteoporos Int; 2014 Dec; 25(12):2777-86. PubMed ID: 25112720
[TBL] [Abstract][Full Text] [Related]
16. Undertreatment of osteoporosis in persons with dementia? A population-based study.
Haasum Y; Fastbom J; Fratiglioni L; Johnell K
Osteoporos Int; 2012 Mar; 23(3):1061-8. PubMed ID: 21499775
[TBL] [Abstract][Full Text] [Related]
17. Managing osteoporosis in ulcerative colitis: something new?
Piodi LP; Poloni A; Ulivieri FM
World J Gastroenterol; 2014 Oct; 20(39):14087-98. PubMed ID: 25339798
[TBL] [Abstract][Full Text] [Related]
18. Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study.
Ensrud KE; Taylor BC; Peters KW; Gourlay ML; Donaldson MG; Leslie WD; Blackwell TL; Fink HA; Orwoll ES; Schousboe J;
BMJ; 2014 Jul; 349():g4120. PubMed ID: 24994809
[TBL] [Abstract][Full Text] [Related]
19. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
Wright NC; Saag KG; Dawson-Hughes B; Khosla S; Siris ES
Osteoporos Int; 2017 Apr; 28(4):1225-1232. PubMed ID: 27966104
[TBL] [Abstract][Full Text] [Related]
20. Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
Cui L; He T; Jiang Y; Li M; Wang O; Jiajue R; Chi Y; Xu Q; Xing X; Xia W
Osteoporos Int; 2020 Feb; 31(2):307-316. PubMed ID: 31754756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
